← all requestsFOIA-014FDAFederalFiled — Awaiting Response
FAERS Adverse Event Reports, Morgellons/Dermopathy Treatment Agents
filed 2026-03-22Emailfdafoia@fda.hhs.gov
→ next escalation: Follow-up letter citing 5 U.S.C. § 552(a)(6)(A)
Deadlines
Determination due (20 business days): 2026-04-17 · 5 U.S.C. § 552(a)(6)(A)(i)
Timeline
- 2026-03-22submitted — Email
Update status
Escalation — Follow-up letter
This request is past its statutory deadline.